SCHEMBL21389366

SCHEMBL21389366

Cc1ccc2c(c1)C(=O)N(CCNC(=O)CC(=O)O)C2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.50
LPAR3 Q9UBY5 1/20 0.50
CHRM2 P08172 2/20 0.48
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CACNA1G O43497 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21389360 0.92 CHRM2 (0.52) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL25391043 0.89 CHRM2 (0.52) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL26746247 0.88 CHRM2 (0.47) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL26259506 0.88 CHRM2 (0.49) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL26185995 0.86 LPAR1 (0.48) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL26579770 0.84 CHRM2 (0.46) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL26746326 0.81 HDAC3 (0.43) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL24795293 0.81 HDAC3 (0.46) LPAR1LPAR3CHRM2HDAC3HDAC4
SCHEMBL24795936 0.81 ALDH1A1 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL21389296 0.81 NPC1 (0.47) CHRM2HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 US disclosed
WO-2019183577-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR LPAR1 48/4885LPAR3 76/4885CHRM2 701/4885
US-11535660-B1 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR LPAR1 45/4885LPAR3 67/4885CHRM2 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.